Eligibility of Individuals With Subclinical Coronary Artery Calcium and Intermediate Coronary Heart Disease Risk for Reclassification (from the Framingham Heart Study)
To access this article, please choose from the options below
This work was supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195), Framingham, Massachusetts.
PII: S0002-9149(09)00602-X
doi:10.1016/j.amjcard.2009.02.020
Published by Elsevier Inc.
